These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35396090)

  • 21. What is the optimal lipid emulsion for preventing intestinal failure-associated liver disease following parenteral feeding in a rat model of short-bowel syndrome?
    Machigashira S; Kaji T; Onishi S; Yano K; Harumatsu T; Yamada K; Yamada W; Matsukubo M; Muto M; Ieiri S
    Pediatr Surg Int; 2021 Feb; 37(2):247-256. PubMed ID: 33388967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic steatosis due to total parenteral nutrition: the influence of short-gut syndrome, refeeding, and small bowel transplantation.
    Langrehr JM; Reilly MJ; Banner B; Warty VJ; Lee KK; Schraut WH
    J Surg Res; 1991 Apr; 50(4):335-43. PubMed ID: 1902273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.
    Pappo I; Bercovier H; Berry E; Gallilly R; Feigin E; Freund HR
    JPEN J Parenter Enteral Nutr; 1995; 19(1):80-2. PubMed ID: 7658606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe Intestinal Dysbiosis in Rat Models of Short Bowel Syndrome with Ileocecal Resection.
    Huang Y; Chen A; Guo F; Wang J; Li Y
    Dig Dis Sci; 2020 Feb; 65(2):431-441. PubMed ID: 31441001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological liver steatosis linked with high parenteral glucose and amino acid supply in infants with short bowel syndrome.
    Gunnar R; Mutanen A; Merras-Salmio L; Pakarinen MP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):41-50. PubMed ID: 35633305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.
    Hu X; Cheng W; Fan S; Huang Y; Chen X; Jiang Z; Wang J
    BMC Infect Dis; 2021 Jun; 21(1):583. PubMed ID: 34134659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity and mortality of short-bowel syndrome in infants with abdominal wall defects.
    Thakur A; Chiu C; Quiros-Tejeira RE; Reyen L; Ament M; Atkinson JB; Fonkalsrud EW
    Am Surg; 2002 Jan; 68(1):75-9. PubMed ID: 12467323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment.
    Zhou X; Li YX; Li N; Li JS
    World J Gastroenterol; 2001 Feb; 7(1):66-73. PubMed ID: 11819735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of bacterial translocation in four different models of experimental short bowel syndrome].
    Asensio AB; García-Urkia N; Aldazabal P; Bachiller P; García-Arenzana JM; Eizaguirre I
    Cir Pediatr; 2003 Jan; 16(1):20-5. PubMed ID: 12793289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional management of infants with short bowel syndrome.
    Wessel JJ; Kocoshis SA
    Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous Secretin Improves Parenteral Nutrition-associated Liver Disease in Rats.
    Cao X; Feng F; Liu X; Sun C; Yang X; Fang Y; Li S
    J Pediatr Gastroenterol Nutr; 2020 Apr; 70(4):430-435. PubMed ID: 32022775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
    Villalona G; Price A; Blomenkamp K; Manithody C; Saxena S; Ratchford T; Westrich M; Kakarla V; Pochampally S; Phillips W; Heafner N; Korremla N; Greenspon J; Guzman MA; Kumar Jain A
    JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1238-1251. PubMed ID: 29701901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilirubin impairs intestinal regrowth following massive small bowel resection in a rat model.
    Sukhotnik I; Shaoul R; Lieber M; Coran AG; Abassi Z; Shiloni E; Mogilner JG
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):16-22. PubMed ID: 19465868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure.
    Koopmann MC; Chen X; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1222-30. PubMed ID: 20864657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired intestinal FXR signaling is involved in aberrant stem cell function leading to intestinal failure-associated liver disease in pediatric patients with short bowel syndrome.
    Zhao Y; Wang Y; Jiang L; Cai W; Yan J
    FASEB J; 2024 Aug; 38(15):e23847. PubMed ID: 39096137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
    Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
    J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated liver transplantation for liver failure in patients with short bowel syndrome.
    Lawrence JP; Dunn SP; Billmire DF; Falkenstein K; Vinocur CD; Weintraub WH
    J Pediatr Surg; 1994 Jun; 29(6):751-3. PubMed ID: 8078012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of glutamine-supplemented parenteral nutrition on intestinal amino acid metabolism in rats after small bowel resection.
    Chen K; Nezu R; Sando K; Haque SM; Iiboshi Y; Masunari A; Yoshida H; Kamata S; Takagi Y; Okada A
    Surg Today; 1996; 26(8):618-23. PubMed ID: 8855495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.
    Barron LK; Bao JW; Aladegbami BG; Colasanti JJ; Guo J; Erwin CR; Warner BW
    J Pediatr Surg; 2017 Jun; 52(6):1014-1019. PubMed ID: 28351520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.